Zymeworks (ZYME) has the following price history information. Looking back at ZYME historical stock prices for the last five trading days, on April 29, 2024, ZYME opened at $8.27, traded as high as $8.58 and as low as $8.25, and closed at $8.33. Trading volume was a total of 438.50K shares. On April 30, 2024, ZYME opened at $8.31, traded as high as $8.64 and as low as $8.26, and closed at $8.58. Trading volume was a total of 699.80K shares. On May 01, 2024, ZYME opened at $8.56, traded as high as $9.00 and as low as $8.55, and closed at $8.76. Trading volume was a total of 888.10K shares. On May 02, 2024, ZYME opened at $8.85, traded as high as $9.23 and as low as $8.65, and closed at $9.00. Trading volume was a total of 853.40K shares. On May 03, 2024, ZYME opened at $8.84, traded as high as $9.24 and as low as $8.53, and closed at $9.20. Trading volume was a total of 655.70K shares.

ZYME Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Zymeworks shares, starting with a $10,000 purchase of ZYME, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	05/01/2017
End date:	05/03/2024
Start price/share:	$13.07
End price/share:	$9.20
Dividends collected/share:	$0.00
Total return:	-29.61%
Average Annual Total Return:	-4.88%
Starting investment:	$10,000.00
Ending investment:	$7,041.49
Years:	7.01

ZYME Historical Price Range
Date	Open	High	Low	Close	Volume
04/29/2024	$8.27	$8.58	$8.25	$8.33	438.50K
04/30/2024	$8.31	$8.64	$8.26	$8.58	699.80K
05/01/2024	$8.56	$9.00	$8.55	$8.76	888.10K
05/02/2024	$8.85	$9.23	$8.65	$9.00	853.40K
05/03/2024	$8.84	$9.24	$8.53	$9.20	655.70K

About Zymeworks

Zymeworks is a clinical-stage biopharmaceutical company focused on the development of multifunctional biotherapeutics. Co.'s primary product candidate, zanidatamab, is a bispecific (dual-targeting) antibody that targets two domains of the human epidermal growth factor receptor 2. Co.'s second product candidate, ZW49, combines the design of zanidatamab with its ZymeLink antibody-drug conjugate platform, comprised of its proprietary cytotoxin (cancer cell-killing compound) and cleavable linker. Co. is also developing a pipeline of preclinical product candidates and discovery-stage programs in oncology (including immuno-oncology agents) and other therapeutic areas.

ZYME Historical Closing Prices
Date	Close
04/29/2024	$8.33
04/30/2024	$8.58
05/01/2024	$8.76
05/02/2024	$9.00
05/03/2024	$9.20

ZYME Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.